Two Sigma Securities’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Two Sigma Securities’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-26,853	Closed	-$2K	–	3299
2022 Q2	$2K	Buy	+26,853	New	+$2.64K	﹤0.01%	2147

Other funds holding CRXTW

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Two Sigma Securities's CRXTW Position: Q3 2022 in Review

Two Sigma Securities sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q3 2022, closing a stake of 26,853 shares — an estimated $2K sold.

Two Sigma Securities first reported a position in CRXTW in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 5 funds tracked by Wall St. Rank hold CRXTW as of Q3 2022.

Two Sigma Securities reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
Two Sigma Securities sold 26,853 Clarus Therapeutics Holdings, Inc. Warrants shares in Q3 2022, an estimated $2K.
Two Sigma Securities first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q2 2022 and held it in 1 quarter.
Two Sigma Securities's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $2K in Q2 2022.
5 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.